个人简历

梁剑铭，杏林青年学者（校聘研究员）。2018于复旦大学获得博士学位，并先后于2012年与2014年间于中国科学院上海药物研究所和中国医药工业研究总院进行联合培养。2018年11月入职广州中医药大学热带医学研究所。近年来，以第一作者在Nano research；ACS applied materials & interfaces等国际著名期刊上发表SCI论文多篇。
教育背景：
2007.9-2011.7 广州中医药大学，攻读学士学位，专业为中药学，学士
2011.9-2014.7 广州中医药大学，攻读硕士学位，专业为中西医结合基础，硕士
2012.7-2014.7 中国科学院上海药物研究所，联合培养，制剂研究，联合培养
2014.7-2018.6 复旦大学，中国医药工业研究总院，联合培养，博士研究生
科研项目
1. 高水平大学建设杏林人才科研配套经费，2018/11-2021/11.
2. 智能化递药教育部重点实验室开放课题，2018/10-2020/10.

研究领域

纳米靶向智能递药系统的研究；中药抗肿瘤研究等。""

近期论文

1. 梁剑铭、曾峰、陈应之、谭娇、陶鹏宇、徐勤、黄永焯. 低分子量鱼精蛋白介导的天花粉蛋白的抗肿瘤应用[J]. 广州中医药大学学报, 2014, 31(5): 780-785.
2.Jianming Liang, Ruixiang Li, Yuwei He, Chengli Ling, Qi Wang, Yongzhuo Huang, Jing Qin, Weigen Lu* and Jianxin Wang*. A Novel Tumor Targeting Treatment Strategy through Energy Restriction by Co-delivery of Albendazole and Nano-silver, Nano research, DOI:10.1007/s12274-018-2032-x.
3. Jianming Liang, Gao Caifang, Zhu Ying, Ling Chengli, Wang Qi, Huang Yongzhuo, Qin Jing, Wang Jue, Lu Weigen*, Wang Jianxin*. New Brain Penetration Enhancers Modified Albumin for Glioma Targeting Delivery. ACS applied materials & interfaces, DOI: 10.1021/acsami.8b11782.
4.Jianming Liang, Feng Zeng, Meng Zhang, Zhenzhen Pan, Jiao Tan, Yuaner Zeng, Qin Xu*, Yongzhuo Huang. Green synthesis of hyaluronic acid-based silver nanoparticles and their enhanced delivery to CD44+ cancer cells, Rsc Advances 5(54) (2015) 43733-43740.
5. Yisi Tang‡, Jianming Liang‡, Aihua Wu, Yingzhi Chen, Pengfei Zhao, Tingting Lin, Meng Zhang, Qin Xu*, Jianxin Wang*, and Yongzhuo Huang*. Co-Delivery of Trichosanthin and Albendazole by Nano-Self-Assembly for Overcoming Tumor Multidrug-Resistance and Metastasis[J]. ACS applied materials & interfaces, 2017, 9(32): 26648-26664. (‡co-first author).
6. Ruixiang Li, Jianming Liang, Yuwei He, Jing Qin, Huining He, Seungjin Lee, Zhiqing Pang and Jianxin Wang*. Sustained Release of Immunosuppressant by Nanoparticle-anchoring Hydrogel Scaffold Improved the Survival of Transplanted Stem Cells and Tissue Regeneration[J]. Theranostics, 2018, 8(4): 878.
7. Chengli Ling, Jianming Liang, Chun Zhang, Ruixiang Li, QianqianMou, Jin Qin, Xiaofang Li and Jianxin Wang*. Molecules 2018, 23(3), 564; doi:10.3390/molecules23030564.
8. Huiyuan Wang, Huixin Wang, Jianming Liang, Yifan Jiang, QianqianGuo, Huige Peng, Qin Xu, and Yongzhuo Huang. Cell-penetrating apoptotic peptide/p53 DNA nanocomplex as adjuvant therapy for drug-resistant breast cancer[J]. Molecular pharmaceutics, 2014, 11(10): 3352-3360.
9. Baoyu Chen, Man Luo,Jianming Liang, Chun Zhang, Caifang Gao, Jue Wang, Jianxin Wang, Yongji Li, Desheng Xu, Lin Liu, Ning Zhang, Huijun Chen, Jing Qin. Surface modification of PGP for a neutrophil–nanoparticle co-vehicle to enhance the anti-depressant effect of baicalein[J]. ActaPharmaceuticaSinica B, 2017, 8(1):64-73.
10. Yaping Wang, Yifan Jiang, Meng Zhang, Jiao Tan, Jianming Liang, Huixin Wang, Yaping Li, Huining He, Victor C. Yang Yongzhuo Huang. Protease‐Activatable Hybrid Nanoprobe for Tumor Imaging[J]. Advanced Functional Materials, 2014, 24(34): 5443-5453.
11. Chun Zhang,Chengli Ling, Liang Pang, Qi Wang, Jingxin Liu, Bingshan Wang, Jianming Liang, Yi-zhenGuo, Jing Qin and Jianxin Wang. Direct Macromolecular Drug Delivery to Cerebral Ischemia Area using Neutrophil-Mediated Nanoparticles.[J]. Theranostics, 2017, 7(13):3260.